Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

PURPOSE: Evaluation of 1-year safety profile of intravitreal ranibizumab 0.5 mg in neovascular age-related macular degeneration (NV-AMD) within routine clinical practice. METHODS: The LUMINOUS programme comprises a prospective observational study assessing ranibizumab ‘real-world’ safety and clinica...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Holz, Frank G, Bandello, Francesco, Gillies, Mark, Mitchell, Paul, Osborne, Aaron, Sheidow, Tom, Souied, Eric, Figueroa, Marta S
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2013
主題:
Clinical Science
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3756427/
https://ncbi.nlm.nih.gov/pubmed/23850682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2013-303232
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍